Cargando…
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice
SIMPLE SUMMARY: The National Comprehensive Cancer Network recommends somatic tumor testing for all patients with epithelial ovarian cancer, as harboring specific mutations has implications for therapy. Targeted panel testing includes some of these genes; however, Next Generation Sequencing is prefer...
Autores principales: | Rives, Taylor A., Pavlik, Heather, Li, Ning, Qasrawi, Lien, Yan, Donglin, Pickarski, Justine, Dietrich, Charles S., Miller, Rachel W., Ueland, Frederick R., Kolesar, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296686/ https://www.ncbi.nlm.nih.gov/pubmed/37370804 http://dx.doi.org/10.3390/cancers15123192 |
Ejemplares similares
-
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
por: Gorski, Justin W., et al.
Publicado: (2020) -
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
por: Schweer, David, et al.
Publicado: (2022) -
SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023) -
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021) -
Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – Navigating maintenance therapy for homologous recombinant proficient ovarian cancer
por: Goldsberry, Whitney N., et al.
Publicado: (2022)